Glow 7 Blend 70mg: Product Details, Quality and Ordering
The glow peptide name comes from the skin and tissue research the blend is associated with, but the product is not a single molecule. It combines separate peptides, each with its own structure and research history, which makes documentation more important than it is for a single compound.
At Peptide King, our Glow 7 70mg blend is listed as a lyophilized research material with a 70mg nominal quantity, ≥98% HPLC-verified purity, and storage at -20°C protected from light. It is supplied exclusively for in-vitro laboratory research.
This guide explains what is in the blend, what researchers have studied about each component, and which quality details deserve attention before laboratory use.
What Is the Glow Peptide Blend?
The product page describes Glow 7 as a blend for skin and tissue research, including dermal matrix, collagen synthesis and tissue remodelling models.
The Batch CoA Identifies the Components
The Certificate of Analysis linked on the product page identifies the blend’s components as GHK-Cu, BPC-157 and thymosin beta-4.
The report states that analysis was performed by HPLC with UV detection coupled with mass spectrometry, and it reports a purity of 99.808%.
A Blend Is Not a Single Compound
Each component has its own sequence, molecular weight and evidence base. A blend combines them in one vial, but it does not combine their literature into a single body of evidence.
What Has Research Studied About Each Component?
Most research on these peptides is preclinical. That distinction should remain visible whenever the blend is discussed.
GHK-Cu Is Studied in Matrix and Skin Biology
GHK is the tripeptide glycine-histidine-lysine, first identified in human plasma. It binds copper to form GHK-Cu.
Research has examined GHK-Cu in collagen and extracellular matrix synthesis, wound models and skin biology, including cosmetic research on topical formulations. Peptide King also lists GHK-Cu 50mg as a single compound.
BPC-157 Is Studied in Tissue Repair Models
BPC-157 is a 15-amino-acid synthetic peptide based on a sequence from a gastric protein. Most published work uses rodent models of tendon, muscle, gut and wound healing.
Thymosin Beta-4 Is Studied in Cell Migration
Thymosin beta-4 is a 43-amino-acid peptide that binds actin. It has been studied in cell migration, wound healing and tissue repair models.
“TB-500” is a name commonly used in research catalogs for synthetic material related to thymosin beta-4. The two terms are not always used consistently, so the CoA identity result deserves attention.
How Strong Is the Human Evidence for the Glow Blend?
We have not identified published clinical trials evaluating this combination of GHK-Cu, BPC-157 and thymosin beta-4.
Evidence for each component comes mostly from cell and animal models, and findings for one peptide cannot be transferred to the combination. The blend therefore has no established human efficacy or safety profile. Peptide King presents it as laboratory research material, not a cosmetic or medical treatment.
What Does the Peptide King Glow 7 Page Specify?
The live Glow 7 70mg research product page gives researchers several details directly.
The Listed Specifications
The current page identifies:
- Quantity: 70mg total blend
- Form: lyophilized powder
- Purity: ≥98% HPLC verified
- Storage: -20°C protected from light
- Documentation: linked Certificate of Analysis
What the Current Glow 7 Page Does Not Show
The page does not list the nominal amount of each component or their molecular weights.
For a blend, the split between components matters as much as the total. The CoA reports measured amounts for each peptide, and comparing those results with the intended formula requires knowing the nominal amount of each.
Purity in a Blend Needs Careful Reading
A single purity figure for a multi-component blend summarizes the chromatographic profile across all components. It does not show whether each peptide is present at its intended amount.
Per-component identity and measured content answer those questions.
Why Does a Certificate of Analysis Matter for a Peptide Blend?
A CoA should connect analytical testing to the actual material being procured, and for a blend it should do that for every component.
Check Every Component, Not Only the Total
Researchers should look for:
| CoA field | What to verify |
|---|---|
| Components | Each peptide is named individually |
| Identity | Mass spectrometry supports each component |
| Measured amount | Reported per component |
| Nominal formula | Available for comparison |
| Purity | Method and result are reported |
| Lot number | Matches current inventory |
| Test date | Relevant to the current batch |
How Does the Glow Blend Compare With Single Peptides?
Blends are convenient, but they make it harder to attribute an observed effect to one molecule.
Single Compounds Suit Studies That Isolate One Variable
Peptide King also lists a TB-500 + BPC-157 blend and GHK-Cu 50mg.
Researchers studying one pathway may prefer single-compound material, while those studying combined effects need clear per-component documentation for the blend.
How Does Canadian Fulfillment Work?
Peptide King fulfills research orders within Canada.
Domestic Processing Follows the Site’s Standard Timeline
The site states that orders are typically processed within one to two business days, with standard shipping estimated at three to seven business days depending on province. Tracking is provided after dispatch.
How We Present Glow 7 Blend 70mg at Peptide King
At Peptide King, we present the Glow blend as a combination of research peptides, each with its own mostly preclinical evidence base.
The name points to skin research, but the quality questions are about composition.
Researchers should confirm each component, compare measured amounts with the intended formula, verify the lot, and keep single-peptide findings separate from claims about the blend.
For a research-grade glow peptide blend, knowing what is in the vial is the first quality check.